Paper228167
Activation of the alternative pathway of guinea pig complement by Sendai virus-treated cells.
Okada N and 2 others. Microbiol Immunol, 1979. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Activation of the alternative pathway of guinea pig complement by Sendai virus-treated cells. Papers, record 228167. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/228167
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Activation of the alternative pathway of guinea pig complement by Sendai virus-treated cells.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Complement Activation | Major topic |
| Complement Pathway, Alternative | Major topic |
| Parainfluenza Virus 1, Human | Major topic |
| Animals | |
| Chickens | |
| Complement C4 | |
| Cycloheximide | |
| Guinea Pigs | |
| HeLa Cells | |
| Hemagglutination Inhibition Tests | |
| Time Factors |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 28670306 | Complement Evasion Strategies of Viruses: An Overview. | Front Microbiol | 2017 | https://conductscience.org/library/papers/28670306 | PubMed |
| 16651386 | Protective immune responses against West Nile virus are primed by distinct complement activation pathways. | J Exp Med | 2006 | https://conductscience.org/library/papers/16651386 | PubMed |
| 7069409 | Appearance of complement components and immunoglobulins on nasopharyngeal epithelial cells following naturally acquired infection with respiratory syncytial virus. | J Med Virol | 1982 | https://conductscience.org/library/papers/7069409 | PubMed |
| 6744659 | Virus-induced complement activation and neutrophil-mediated cytotoxicity against respiratory syncytial virus (RSV). | Clin Exp Immunol | 1984 | https://conductscience.org/library/papers/6744659 | PubMed |
| 6301976 | Cytolysis of Sendai virus-infected guinea-pig cells by homologous complement. | Immunology | 1983 | https://conductscience.org/library/papers/6301976 | PubMed |
| 6265347 | Sendai virus infected cells are readily cytolysed by guinea-pig complement without antibody. | Immunology | 1981 | https://conductscience.org/library/papers/6265347 | PubMed |
| 3954599 | Complement activation by respiratory syncytial virus-infected cells. | Arch Virol | 1986 | https://conductscience.org/library/papers/3954599 | PubMed |
| 3594492 | Sensitization of human tumor cells to homologous complement by vaccinia virus treatment. | Cancer Immunol Immunother | 1987 | https://conductscience.org/library/papers/3594492 | PubMed |
| 3003397 | Effect of complement depletion by cobra venom factor on fowlpox virus infection in chickens and chicken embryos. | J Virol | 1986 | https://conductscience.org/library/papers/3003397 | PubMed |
| 2511185 | Tumor cells treated with vaccinia virus can activate the alternative pathway of mouse complement. | Jpn J Cancer Res | 1989 | https://conductscience.org/library/papers/2511185 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/228167
GET https://conductscience.org/api/papers/v1/228167/authors